Zanganeh Maky's Form 4 filing
Summit Therapeutics Inc. (SMMT) · filed Aug 18, 2022
- Accession no.
- 0001387131-22-008886
- Filed
- Aug 18, 2022
- Trade date
- Aug 16, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $5.63M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zanganeh MakyCIK 0001507650 | Director, Officer (Co-CEO & President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 | Common Stock | PPurchaseAcquired | +184,430 | $0.97 | +$178,897.1 | 359,969 | Direct | |
| Aug 16, 2022 | Common Stock | PPurchaseAcquired | +4,593,777 | $0.97 | +$4,455,963.69 | 7,061,557 | Indirect | |
| Aug 16, 2022 | Common Stock | PPurchaseAcquired | +1,030,925 | $0.97 | +$999,997.25 | 3,135,466 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.